Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charter Communications
CHTR
|
+$601M |
| 2 |
Parker-Hannifin
PH
|
+$576M |
| 3 |
JPMorgan Chase
JPM
|
+$575M |
| 4 |
Goldman Sachs
GS
|
+$452M |
| 5 |
FedEx
FDX
|
+$371M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$733M |
| 2 |
American Tower
AMT
|
+$684M |
| 3 |
Nike
NKE
|
+$601M |
| 4 |
AGN
Allergan plc
AGN
|
+$561M |
| 5 |
McDonald's
MCD
|
+$536M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.7% |
| 2 | Consumer Discretionary | 17.46% |
| 3 | Healthcare | 13.37% |
| 4 | Communication Services | 12.12% |
| 5 | Financials | 11.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
RLI Corp
RLI
$5.88B
| $2.05M | ﹤0.01% |
65,004
+6,278
| +11% | +$194K |
|
552
Semtech
SMTC
$11.3B
| $2.04M | ﹤0.01% |
64,778
-2,676
| -4% | -$74.9K |
|
553
Plexus
PLXS
$6.78B
| $1.97M | ﹤0.01% |
36,520
-3,600
| -9% | -$178K |
|
554
Wave Life Sciences
WVE
$1.14B
| $1.97M | ﹤0.01% |
75,435
| – | – |
|
555
Yum! Brands
YUM
$40.7B
| $1.97M | ﹤0.01% |
+31,038
| New | +$1.95M |
|
|
DD
556
DELISTED
Du Pont De Nemours E I
DD
| $1.9M | ﹤0.01% |
25,899
+21,934
| +553% | +$1.56M |
|
557
Lincoln National
LNC
$7.88B
| $1.89M | ﹤0.01% |
+28,586
| New | +$1.66M |
|
558
Oracle
ORCL
$345B
| $1.89M | ﹤0.01% |
49,190
+21,100
| +75% | +$825K |
|
559
Adtran
ADTN
$769M
| $1.88M | ﹤0.01% |
84,263
-10,064
| -11% | -$203K |
|
|
RTN
560
DELISTED
Raytheon Company
RTN
| $1.86M | ﹤0.01% |
+13,129
| New | +$1.87M |
|
561
3M
MMM
$91.9B
| $1.85M | ﹤0.01% |
+12,401
| New | +$1.79M |
|
|
CMO
562
DELISTED
Capstead Mortgage Corp.
CMO
| $1.73M | ﹤0.01% |
169,844
-7,425
| -4% | -$72.9K |
|
|
DCOY
563
Decoy Therapeutics
DCOY
$1.99M
| – | – |
-1
| Closed | -$6.1M |
|
564
Aon
AON
$78.4B
| $1.72M | ﹤0.01% |
+15,422
| New | +$1.72M |
|
565
Piper Sandler
PIPR
$5.15B
| $1.65M | ﹤0.01% |
91,240
-2,540
| -3% | -$40.1K |
|
566
Mohawk Industries
MHK
$7.05B
| $1.65M | ﹤0.01% |
+8,270
| New | +$1.62M |
|
567
Tyson Foods
TSN
$21.4B
| $1.6M | ﹤0.01% |
+25,886
| New | +$1.7M |
|
568
Medtronic
MDT
$108B
| $1.59M | ﹤0.01% |
22,356
-528,183
| -96% | -$41.5M |
|
|
SAFM
569
DELISTED
Sanderson Farms Inc
SAFM
| $1.56M | ﹤0.01% |
16,603
+8,529
| +106% | +$754K |
|
570
Gilead Sciences
GILD
$162B
| $1.53M | ﹤0.01% |
+21,348
| New | +$1.59M |
|
571
Gartner
IT
$9.87B
| $1.48M | ﹤0.01% |
14,684
-24
| -0.2% | -$2.32K |
|
572
RBC Bearings
RBC
$18.5B
| $1.46M | ﹤0.01% |
15,687
-437
| -3% | -$35.2K |
|
573
Progressive
PGR
$125B
| $1.41M | ﹤0.01% |
39,830
-36,358
| -48% | -$1.2M |
|
574
Trip.com Group
TCOM
$28.2B
| $1.41M | ﹤0.01% |
35,316
+25,089
| +245% | +$1.1M |
|
575
State Street Energy Select Sector SPDR ETF
XLE
$38.8B
| $1.41M | ﹤0.01% |
37,322
-920
| -2% | -$33.3K |
|
Similar funds
Jennison Associates's Q4 2016 Portfolio in Review
As of Q4 2016, Jennison Associates held 857 positions worth $89.6B, down 3.4% from $92.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Jennison Associates withdrew a net $3.76B in Q4 2016, closing 52 positions and reducing 313 holdings. Its most notable exit was lululemon athletica, an estimated $342M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in Parker-Hannifin worth $606M.
- Jennison Associates's largest Q4 2016 buy was Parker-Hannifin: 4,330,276 shares worth $606M.
- Jennison Associates added most to Charter Communications in Q4 2016, an estimated $601M increase.
- Jennison Associates's biggest Q4 2016 reduction was Biogen, cutting an estimated $733M.
- Jennison Associates fully exited lululemon athletica in Q4 2016, selling an estimated $342M.
- Jennison Associates's ten largest holdings make up 25% of its $89.6B portfolio in Q4 2016.
- Jennison Associates opened 208 new positions and closed 52 in Q4 2016.
- Jennison Associates's portfolio value fell 3.4% quarter-over-quarter to $89.6B.
Based on Jennison Associates's 13F filing for Q4 2016, filed 6 Feb 2017.